Goldman Sachs Group Inc Avanos Medical, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 418,417 shares of AVNS stock, worth $6.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
418,417
Previous 177,954 135.13%
Holding current value
$6.7 Million
Previous $3.54 Million 183.69%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$19.21 - $24.69 $4.62 Million - $5.94 Million
240,463 Added 135.13%
418,417 $10.1 Million
Q2 2024

Aug 13, 2024
BUY
$17.85 - $20.42 $261,573 - $299,234
14,654 Added 8.97%
177,954 $3.54 Million
Q1 2024

May 15, 2024
SELL
$17.97 - $22.68 $9.46 Million - $11.9 Million
-526,337 Reduced 76.32%
163,300 $3.25 Million
Q4 2023

Feb 13, 2024
SELL
$17.64 - $22.99 $442,270 - $576,405
-25,072 Reduced 3.51%
689,637 $15.5 Million
Q3 2023

May 14, 2024
BUY
$19.93 - $26.31 $499,684 - $659,644
25,072 Added 3.64%
714,709 $14.5 Million
Q3 2023

Nov 14, 2023
SELL
$19.93 - $26.31 $4.91 Million - $6.48 Million
-246,233 Reduced 25.62%
714,709 $14.5 Million
Q2 2023

May 14, 2024
SELL
$22.53 - $30.98 $369,266 - $507,762
-16,390 Reduced 1.68%
960,942 $24.6 Million
Q2 2023

Aug 14, 2023
SELL
$22.53 - $30.98 $369,266 - $507,762
-16,390 Reduced 1.68%
960,942 $24.6 Million
Q1 2023

May 14, 2024
SELL
$26.92 - $31.75 $10.2 Million - $12 Million
-378,365 Reduced 27.91%
977,332 $29.1 Million
Q1 2023

May 11, 2023
SELL
$26.92 - $31.75 $10.2 Million - $12 Million
-378,365 Reduced 27.91%
977,332 $29.1 Million
Q4 2022

May 14, 2024
SELL
$19.88 - $27.37 $4.34 Million - $5.98 Million
-218,554 Reduced 13.88%
1,355,697 $36.7 Million
Q4 2022

Feb 13, 2023
SELL
$19.88 - $27.37 $4.34 Million - $5.98 Million
-218,554 Reduced 13.88%
1,355,697 $36.7 Million
Q3 2022

May 14, 2024
SELL
$21.56 - $29.59 $6.57 Million - $9.02 Million
-304,776 Reduced 16.22%
1,574,251 $34.3 Million
Q3 2022

Nov 10, 2022
SELL
$21.56 - $29.59 $6.57 Million - $9.02 Million
-304,776 Reduced 16.22%
1,574,251 $34.3 Million
Q2 2022

May 14, 2024
BUY
$24.87 - $34.68 $29.6 Million - $41.2 Million
1,189,390 Added 172.47%
1,879,027 $51.4 Million
Q2 2022

Aug 15, 2022
SELL
$24.87 - $34.68 $2.98 Million - $4.16 Million
-119,844 Reduced 6.0%
1,879,027 $51.4 Million
Q1 2022

May 16, 2022
BUY
$28.87 - $35.77 $11.3 Million - $14.1 Million
392,870 Added 24.46%
1,998,871 $67 Million
Q4 2021

Feb 14, 2022
BUY
$29.25 - $36.02 $4.98 Million - $6.13 Million
170,306 Added 11.86%
1,606,001 $55.7 Million
Q3 2021

Nov 10, 2021
BUY
$31.2 - $38.5 $44.8 Million - $55.3 Million
1,435,695 New
1,435,695 $44.8 Million

Others Institutions Holding AVNS

# of Institutions
274
Shares Held
42.2M
Call Options Held
5.4K
Put Options Held
5K
View Full List

About AVANOS MEDICAL, INC.

AVNS Quotes by TradingView
  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $745M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email